← Back to Clinical Trials
Recruiting NCT06800898

NCT06800898 Orexin Gene in Anorexia Nervosa

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06800898
Status Recruiting
Phase
Sponsor Istituto Auxologico Italiano
Condition Anorexia Nervosa
Study Type OBSERVATIONAL
Enrollment 60 participants
Start Date 2024-06-19
Primary Completion 2026-06-30

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Blood samples and Questionnaires

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 60 participants in total. It began in 2024-06-19 with a primary completion date of 2026-06-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The objectives of this study will be to determine the methylation of the promoter of the Orexin A (OX-A) and B (OX-B) genes in young women (\> 18 years) with Anorexia Nervosa (AN), compared with a control group; and to evaluate the relationship of promoter methylation of the genes for OX-A and OX-B with the severity of the eating disorder, psychiatric comorbidities (in particular, depression), and sleep quality.

Eligibility Criteria

Patients with Anorexia Nervosa: Inclusion Criteria: * Female sex * Age 18 years and older * Anorexia Nervosa * Hospitalized at the Division of Eating and Nutrition Disorders, Istituto Auxologico Italiano, IRCCS, Piancavallo, Italy Exclusion Criteria: * Absence of signed informed consent Control group: Inclusion Criteria: * Female sex * Age 18 years and older * Body Mass Index between 18.5 and 24.9 kg/m2 Exclusion Criteria: * Absence of signed informed consent * Presence of any physical and mental pathology

Contact & Investigator

Central Contact

Alessandro Sartorio, MD

✉ sartorio@auxologico.it

📞 +390261911

Frequently Asked Questions

Who can join the NCT06800898 clinical trial?

This trial is open to female participants only, aged 18 Years or older, studying Anorexia Nervosa. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06800898 currently recruiting?

Yes, NCT06800898 is actively recruiting participants. Contact the research team at sartorio@auxologico.it for enrollment information.

Where is the NCT06800898 trial being conducted?

This trial is being conducted at Oggebbio, Italy.

Who is sponsoring the NCT06800898 clinical trial?

NCT06800898 is sponsored by Istituto Auxologico Italiano. The trial plans to enroll 60 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology